SGLT2 inhibitors and incretin-based therapies for metabolic dysfunction-associated steatohepatitis: a systematic review.
Saved in:
| Title: | SGLT2 inhibitors and incretin-based therapies for metabolic dysfunction-associated steatohepatitis: a systematic review. |
|---|---|
| Authors: | Cruz AM; University of Gurupi, Gurupi, Tocantins, Brazil.; Medical Residency in Internal Medicine, Idomed Quixadá, Ceará, Brazil., Lima BCV; Estácio Faculty of Medicine of Juazeiro do Norte, Ceará, Brazil.; Federal University of Cariri, Ceará, Brazil., de Ferreira JESM; University for the International Integration of the Afro-Brazilian Lusophony (UNILAB), Ceará, Brazil. eriveltonsmf@aluno.unilab.edu.br.; Abelardo Gadelha da Rocha Municipal Hospital, Caucaia, Ceará, Brazil. eriveltonsmf@aluno.unilab.edu.br., Teles RB; Medical Residency in Internal Medicine, Idomed Quixadá, Ceará, Brazil.; Abelardo Gadelha da Rocha Municipal Hospital, Caucaia, Ceará, Brazil. |
| Source: | European journal of clinical pharmacology [Eur J Clin Pharmacol] 2026 Jun 10; Vol. 82 (7). Date of Electronic Publication: 2026 Jun 10. |
| Publication Type: | Journal Article; Systematic Review; Review |
| Journal Info: | Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1041 (Electronic) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1432-1041 |
|---|---|
| DOI: | 10.1007/s00228-026-04095-7 |
